NCT02167815

Brief Summary

This investigation is a Post Marketing Follow-Up Study for Mepilex XT conducted as part of Mölnlycke Health Care's quality system. The primary objective is to evaluate the performance of the dressing when used as intended on exuding Venous Leg Ulcers (VLUs) in the inflammatory and granulating stages of the wound healing process.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2014

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

May 15, 2014

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 19, 2014

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

October 26, 2016

Completed
Last Updated

October 26, 2016

Status Verified

May 1, 2014

Enrollment Period

1.2 years

First QC Date

May 15, 2014

Results QC Date

October 13, 2015

Last Update Submit

September 6, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes From Baseline in Condition of the Peri Wound Skin

    Deteriorationin of skin condition , Mepilex XT and Standard care (%)

    16 weeks

Secondary Outcomes (3)

  • Pain Scores on the Visual Analog Scale

    16 weeks

  • Users Feedback After Handling or Use as a Measure of Performance.

    16 weeks

  • Measure of Actual Dressing Cost and Cost of Care, as Input for Health Economics Calculations.

    16 weeks

Study Arms (2)

Standard care

ACTIVE COMPARATOR

standard care ( such as alginate, hydrofiber or other treatment)

Other: standard care

Intervention ( Mepilex XT)

EXPERIMENTAL
Device: Mepilex XT

Interventions

Experimental arm

Intervention ( Mepilex XT)
Standard care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Venous Leg Ulcer
  • Exuding wound
  • Wound surface covered with sloughy tissue\* (before debridement)
  • Wound size ≥ 6 cm2
  • In case of multiple wounds, target wound must be ≥ 3cm distant from other wounds.
  • Wound suitable for treatment with the relevant primary dressing\*\*
  • Male or female, 18 years of age and above
  • Signed Informed Consent
  • Sloughy tissue defined as wet, yellow-brown fibrinous tissue present in the wound bed \*\* Mepilex XT in the intervention group. Standard care in the observation group

You may not qualify if:

  • More than two products of 15 cm x15 cm needed to cover the whole wound and affected peri-wound area
  • Wound cavity and/or fistula
  • Full thickness burns
  • Exposed tendons and/or fascia
  • Bleeding wounds
  • Malignant or fungating wounds
  • Wound age \> 12 months
  • Subject not suitable for the investigation according to the investigator's judgement
  • Subject included in other ongoing clinical investigation which could interfere with this investigation, as judged by the investigator
  • Known allergy/hypersensitivity to any of the components of the primary dressing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Nemocnice Podlesí a.s.

Třinec, Konská 453, 739 61, Czechia

Location

Nemocnice Jihlava

Jihlava, Vrchlického, 586 01, Czechia

Location

The General University Hospital in Prague

Prague, Czechia

Location

MeSH Terms

Conditions

Varicose Ulcer

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Varicose VeinsVascular DiseasesCardiovascular DiseasesLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Results Point of Contact

Title
MuDr Jan Stryja
Organization
Nemocnice Podlesí

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2014

First Posted

June 19, 2014

Study Start

May 1, 2014

Primary Completion

July 1, 2015

Study Completion

July 1, 2015

Last Updated

October 26, 2016

Results First Posted

October 26, 2016

Record last verified: 2014-05

Locations